US FDA changes informed consent requirements
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration is amending its regulations to ensure that informed consent documents and processes for certain drugs, biologics and device trials are changed to notify potential subjects that information about the concerned trial has been, or will be, included in a publicly accessible database (www.ClinicalTrials.gov).